What is Juvenile polyposis syndrome

Juvenile polyposis syndrome (JPS) is a rare genetic disorder characterized by the development of multiple benign growths, called juvenile polyps, in the gastrointestinal tract. These polyps carry an increased risk of developing into colorectal cancer, necessitating regular medical surveillance and management.

What causes Juvenile polyposis syndrome?

Juvenile polyposis syndrome is primarily caused by mutations in the SMAD4 or BMPR1A genes, which are involved in cell signaling pathways that regulate tissue growth. The condition follows an autosomal dominant inheritance pattern, meaning an individual only needs to inherit the mutation from one parent to be at risk for Juvenile polyposis syndrome. However, approximately 25% of cases occur in individuals with no family history, likely due to a new (de novo) mutation.

Who is affected by Juvenile polyposis syndrome?

Juvenile polyposis syndrome is extremely rare, with estimated prevalence rates ranging from 1 in 100,000 to 1 in 160,000 people. While the name suggests it only affects children, the condition can be diagnosed at any age. Symptoms often appear during childhood or early adulthood, though some individuals remain asymptomatic until later in life. There is no significant difference in incidence between males and females, and the condition occurs globally across all ethnic groups.

How does Juvenile polyposis syndrome affect the body?

The primary impact of Juvenile polyposis syndrome is concentrated in the gastrointestinal system. Key clinical features include:

• Development of 5 to 100+ juvenile polyps, usually in the colon or rectum.


• Rectal bleeding, which is often the first clinical sign.


• Abdominal pain, diarrhea, or iron-deficiency anemia due to chronic blood loss.


• Increased lifetime risk of colorectal, gastric, and small bowel cancers.


• Extraintestinal findings, such as digital clubbing or heart defects (primarily in cases involving SMAD4 mutations).

How is Juvenile polyposis syndrome different from other conditions?

Unlike Familial Adenomatous Polyposis (FAP), which involves thousands of adenomatous polyps, Juvenile polyposis syndrome is distinguished by the specific "hamartomatous" histology of the polyps. These polyps are benign, but their presence and the underlying genetic risk factor distinguish this syndrome from sporadic polyp growth.

Next steps

• Consult a gastroenterologist or a genetic counselor to discuss surveillance schedules.


• Consider genetic testing to confirm a diagnosis of Juvenile polyposis syndrome and to screen at-risk family members.


• Join the DiseaseMaps.org community to connect with others sharing experiences with this rare condition.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Juvenile Polyposis Syndrome.


• Orphanet: Juvenile Polyposis Syndrome (ORPHA:731).


• Online Mendelian Inheritance in Man (OMIM): Juvenile Polyposis Syndrome (#174900).


• National Cancer Institute (NCI): Genetics of Colorectal Cancer.